Join NATF in the fight against blood clots. Donate today. Make a donation

Event Description

Earn up to 10.5 CME Credits!

The United States CTEPH Proceedings 2021 will provide a multidisciplinary framework for the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). Covered topics will include:

  • The epidemiology of chronic thromboembolic disease in the US
  • Contemporary approaches to diagnosing CTEPH
  • The latest in surgical advancements
  • The role of pulmonary hypertension (PH) targeted medical therapy and balloon pulmonary angioplasty (BPA) in the management of inoperable CTEPH

The conference format will comprise didactic presentations, debates, and panel discussions involving national and international experts in the field. There will be scheduled opportunities throughout the symposium for interactive audience participation. Attendees will also be encouraged to submit and present scientific abstracts and unique clinical cases related to CTEPH and other large-vessel pulmonary vascular diseases.

Target Audience:

This program has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, interventional cardiologists and radiologists, anesthesiologists, thoracic radiologists, nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with CTEPH.

Learning Objectives:

  1. Discuss an updated understanding of the epidemiology and pathophysiology of CTEPH
  2. Describe the latest diagnostic modalities and evaluative approach to patients with suspected chronic thromboembolic disease
  3. Discuss the advancements in the surgical procedure, pulmonary thromboendarterectomy, currently available for patients with chronic thromboembolic disease and CTEPH
  4. Explain the role of balloon pulmonary angioplasty in the management of inoperable CTEPH
  5. Define the role of pulmonary hypertension targeted medical therapy in selected patient groups with CTEPH

Conference Chair:

  • William R. Auger, MD

Organizing Committee:

  • Sonja Bartolome, MD (University of Texas, Southwestern)
  • Todd Bull, MD (University of Colorado)
  • Richard N. Channick, MD (University of California, Los Angeles)
  • Michael Cuttica, MD (Northwestern University)
  • Gustavo Heresi, MD (Cleveland Clinic)
  • Michael M. Madani, MD (University of California, San Diego)
  • Vallerie McLaughlin, MD (University of Michigan)
  • Ivan Robbins, MD (Vanderbilt University)
  • Anjali Vaidya, MD (Temple University)
  • Alison Witkin, MD (MGH, Harvard University)

Cost:

In-Person Cost:

  • MD/DO: Early Bird Registration (by 7/31) – $349 After 7/31 – $500
  • Nursing and Allied Healthcare Professionals: $250
  • Fellows and Residents: $175
  • Commercial: $650
  • Students: $0 *no CME offered for this registration
  • Your tuition includes
    • 10.5 CME credits
    • Continental breakfast
    • Morning and afternoon coffee breaks
    • Lunch
    • Cocktail/Networking Reception
    • Complimentary internet in the meeting room
    • All attendees will receive a printed syllabus

Virtual Cost:

  • MD/DO: Early Bird Registration (by 7/31) – $249 After 7/31 – $400
  • Nursing and Allied Healthcare Professionals: $150
  • Fellows and Residents: $75
  • Commercial: $550
  • Students: $0 * no CME offered for this registration
  • Your tuition includes
    • Program will be streamed live with the opportunity to submit questions to presenters in real-time
    • 10.5 CME credits
    • PDF version of the syllabus

Call for Scientific Abstracts and Case Reports

Abstract Submission Deadline: Sunday August, 1, 2021 (5:00PM EST)

Content: Subject matter related to all research and clinical (medical, surgical, interventional) aspects of chronic thromboembolic disease and CTEPH. Case reports should preferably discuss unique aspects of the presentation, evaluation, and management of patients with chronic thromboembolic disease, clinical “mimics,” and unexpected outcomes following the treatment of CTEPH patients.

Scientific Abstracts:

Should be organized as follows:

    1. Descriptive title, list of authors (presenting author indicated by an asterisk*), and institution(s)
    2. Introduction, discussing rationale for study
    3. Methods
    4. Study results
    5. Conclusions

Case Reports: 

Case report abstracts should contain the following components:

    1. Descriptive title, list of authors (presenting author indicated by an asterisk*), and institution(s)
    2. Introduction
    3. Description of clinical case
    4. Discussion of the unique and important aspects of the reported case

Abstract Length, Language, and Submission:

The abstract must be submitted in English; the total word count of an abstract should not exceed 400 words (abstract body). Title, author information, tables, and figures/images are not included in the word count. Abstracts should be submitted as a Word file electronically to Dr. William Auger at williamrauger@icloud.com.

Disclosure: 

The presenting author of the submitted abstract must complete an Author Disclosure Form.

Research Funding Source:

All abstracts must specify funding source, such as a grant name, pharmaceutical support, or other funding source. If there is no funding source, indicate “none”.

Abstract Publication: 

Accepted abstracts will not be indexed, though all accepted abstracts will be displayed as posters (poster formatting in acceptance letter) and available for viewing throughout the US CTEPH Proceedings 2021. Recently presented abstracts will be accepted. All accepted abstracts will be published in the final conference program.

Submission Fee:

There is no submission fee. A discounted registration fee will be available to the presenting author of an accepted abstract or case report.

Event Location

The College of Physicians of Philadelphia, Mutter Museum

The Mütter Museum is housed in a beautiful New Beaux-Arts style building, constructed in 1909 and designed by Cope and Stewardson. The magnificent columned Marble Rotunda, with its view of a classic grand staircase, sets the stage for any occasion. The building’s unique spaces are perfect for this symposium.

Hotel Information

NATF recommends the following hotels for your stay, all of which are within a half-mileof the College of Physicians.

Agenda

FRIDAY 

SEPTEMBER 10, 2021

7:00–8:20 AM 
Registration and Breakfast
8:20–8:30 AM 
Welcome: William R. Auger, MD, FCPP
8:30–10:00 AM 
Understanding CTEPH

8:30–9:00 AM: Transition from Acute PE to CTEPH: Implications for Future Therapeutics?
Sudarshan Rajagopal, MD, PhD

9:00-9:30 AM: Screening for Chronic Thromboembolic Disease and CTEPH
F.A. Klok, MD, PhD

9:30–10:00 AM: The Ongoing Challenges of Diagnosing CTEPH
Gustavo Heresi, MD, MS

10:00–10:20 AM 

Coffee Break

10:20 AM–12:00 PM 

The Tools of Diagnosis

10:20–11:00 AM: Advances in CT and MR Imaging: Implications for CTEPH Diagnosis and Management
Deepa Gopalan, FRCP, FRCR

11:00–11:30 AM: The Art of Pulmonary Angiography
Lori Daniels, MD, FACC

11:30 AM–12:00 PM: Exercise Testing in Chronic PE
Paul Forfia, MD

12:00–1:30 PM 

Lunch

1:30–2:45 PM 
Interactive Case Presentations
  1. Symptomatic 6 Months Following a PE…What to Do?
    Peter Hountras, MD
  2. Is That Acute or Chronic Clot On CT?
    Sonja Bartolome, MD
  3. VQ, CT, Pulmonary Angiogram…Is It All Necessary?
    Victor M. Moles, MD
2:45–3:00 PM 

Coffee Break

3:00–5:00 PM 
Surgery, Surgical Management, and Cases That Drive Our Surgical Colleagues Nuts!

3:00–3:20 PM: Distal Endarterectomy in the Setting of Severe PH and High PVR: Should It Be Done
Marc de Perrot, MD

3:20–3:40 PM: “Thou Shall Not Reperfuse Diseased Lungs”: Endarterectomy in the Setting of COPD or Other Chronic Lung Disease – Diagnostic and Technical Challenges
Jonathan Haft, MD

3:40–4:00 PM: Pulmonary Endarterectomy After Previous BPA Sessions With and Without Stent Placement: So, What’s the Big Deal?
Michael Madani, MD, FACS

4:00–4:20 PM: “May I ask for a different patient today?” What to Do When Your Patient Has HIT, Sickle Cell Anemia, Pulmonary Angiosarcoma, or is a Jehovah’s Witness
Victor Pretorius, MBChB

4:20–4:40 PM: The Patient with CTED: To Operate or Not to Operate
Cameron Wright, MD

4:40–5:00 PM: Management of Complex Post-Op Complications – ECMO to the Rescue: Airway Bleeding, Severe Reperfusion Injury, Residual PH and RV Failure
Michael Tong, MD, MBA

5:30–7:30 PM 
Poster Presentation and Cocktail/Networking Reception
SATURDAY  

SEPTEMBER 11, 2021

7:30–8:00 AM 

Breakfast

8:00–8:10 AM 
Conference Announcements: William R. Auger, MD, FCPP
8:10–8:40 AM 

Kenneth M. Moser Distinguished Scholar Lecture
The Challenges of Caring for CTEPH Patients in the U.S.
Kim M. Kerr, MD

8:40–10:00 AM 
Nonsurgical Management of CTEPH: Medical

8:40–9:00 AM: Inoperable CTEPH: Defining the Role of Medical Treatment
Alison Witkin, MD

9:00–9:20 AM: The Hematology of CTEPH: Perioperative Considerations
Richard Channick, MD

9:20–9:40 AM: Post-PTE Anticoagulation, Warfarin vs. DOACs: End of the INR?
Ivan Robbins, MD

9:40-10:00 AM: Life After PTE: Residual PH Assessment and Mechanical VTE Risk Mitigation
Anjali Vaidya, MD, FACC, FASE, FACP

10:00–10:15 AM 

Coffee Break

10:15–11:30 AM 
Balloon Pulmonary Angioplasty: The New Frontier

10:15–10:45 AM: The Great Debate: Distal CTEPH – Getting to the Root of the Problem: PTE or BPA?
Michael Madani, MD, FACS and Robert Frantz, MD

10:45–11:00 AM: Technical Considerations and Challenges in BPA
Riyaz Bashir, MD

11:00–11:15 AM: BPA: How Much BPA Is Enough? Targets, Goals, and Limitations
Richard Krasuski, MD

11:15–11:30 AM: BPA After PTE: Whether to Consider, When to Do It
Ken Rosenfield, MD

11:30 AM–12:30 PM 
Interactive Case Presentations
  1. Medical Management in a Non-PTE Candidate
    Michael Cuttica, MD
  2. Handling Vessel Injury and Hemoptysis After a BPA
    David Poch, MD
  3. BPA Combined with Medical Management in Inoperable CTEPH
    Vladimir Lakhter, DO

Join NATF in the fight against blood clots. Donate today.

Make a donation

Twitter Facebook YouTube